(Q35143216)

6 August 2017

1 reference

title

Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target (English)

1 reference

6 August 2017

0 references

0 references

1 reference

Jeff S Healey

1

1 reference

6 August 2017

Stuart J Connolly

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

American Journal of Cardiology

6 August 2017

published in

1 reference

6 August 2017

volume

91

1 reference

6 August 2017

issue

10A

1 reference

6 August 2017

page(s)

9G-14G

1 reference

Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Incidence of and risk factors for atrial fibrillation in older adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Epidemiologic features of chronic atrial fibrillation: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Embolic complications in paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

The risk of cerebral infarction in non-valvular atrial fibrillation: effects of age, hypertension and antihypertensive treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Left atrial enlargement: an early sign of hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Left atrial size in 164 hypertensive patients: an echocardiographic and ambulatory blood pressure study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Influence of nighttime blood pressure on left atrial size in uncomplicated arterial systemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Influence of blood pressure on left atrial size. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Evaluation of the echocardiogram as an epidemiologic tool in an asymptomatic population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effect of ethnicity and hypertension on atrial conduction: evaluation with high-resolution P-wave signal averaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

The signal-averaged P wave duration: a rapid and noninvasive marker of risk of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

The effect of atrial dilatation on the genesis of atrial arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effect of atrial fibrillation on atrial refractoriness in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Cardiac rhythm in hypertension assessed through 24 hour ambulatory electrocardiographic monitoring. Effects of load manipulation with atenolol, verapamil, and nifedipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Clinical studies of drug reversal of hypertensive left ventricular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

The effects of antihypertensive therapy on left ventricular mass in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with left ventricular remodeling and improved diastolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Structural and functional myocardial responses to chronic treatment with the Ca2+ blocker verapamil (Calan-SR) in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effects of labetalol on left ventricular mass and function in hypertension — An assessment by serial echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Effects of lisinopril in patients with heart failure and chronic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Use of ramipril in preventing stroke: double blind randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

Increased cardiac performance in mild essential hypertension. Left ventricular mechanics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900227-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(03)00227-3

1 reference

6 August 2017

1 reference